Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases.

Mao, Wenhui; Zimmerman, Armand; Urli Hodges, Elina; Ortiz, Ernesto; Dods, Galen; Taylor, Andrea; Udayakumar, Krishna

Mao, Wenhui; Zimmerman, Armand; Urli Hodges, Elina; Ortiz, Ernesto; Dods, Galen; Taylor, Andrea; Udayakumar, Krishna.

Afiliação

Mao W; Duke Global Health Innovation Center, Duke Global Health Institute, Durham, North Carolina, USA wenhui.mao@duke.edu.
Zimmerman A; Innovations in Healthcare, Durham, North Carolina, USA.
Urli Hodges E; Duke Global Health Innovation Center, Duke Global Health Institute, Durham, North Carolina, USA.
Ortiz E; Center for Policy Impact in Global Health, Duke Global Health Institute, Durham, North Carolina, USA.
Dods G; Duke Global Health Innovation Center, Duke Global Health Institute, Durham, North Carolina, USA.
Taylor A; Innovations in Healthcare, Durham, North Carolina, USA.
Udayakumar K; Duke Global Health Innovation Center, Duke Global Health Institute, Durham, North Carolina, USA.

BMJ Glob Health ; 8(9)2023 09.

Article em En | MEDLINE | ID: mdl-37696544

Assuntos

COVID-19; Doenças Transmissíveis; Vacinas; Humanos; Vacinas contra COVID-19; Pandemias/prevenção & controle; COVID-19/prevenção & controle; Pesquisa

Palavras-chave

COVID-19; Vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Doenças Transmissíveis / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: BMJ Glob Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google